MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...
Key opinion leaders explore the necessary synergy between payors and providers for optimizing bispecific therapy. This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, ...
Utilization of the four pillars in heart failure therapy are highlighted as aggressive first-line treatment strategies. This is a video synopsis/summary of a panel discussion involving Robert Groves, ...
Please provide your email address to receive an email when new articles are posted on . PCI was not cost-effective vs. optimal medical therapy alone in patients with CAD and HF. Intervention conferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results